Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Interim Management Statement

21 Apr 2011 07:00

RNS Number : 3112F
Persimmon PLC
21 April 2011
 



INTERIM MANAGEMENT STATEMENT

 

THURSDAY 21 APRIL 2011

 

 

 

Persimmon plc is holding its Annual General Meeting at 12 noon today at York Racecourse where the following comments will be made regarding current trading, financial performance and the outlook for the financial year. This statement, which supplements the update given at the time of our 2010 results, covers the period from 1 January 2011 to the date of this announcement and constitutes Persimmon plc's first Interim Management Statement in 2011.

 

At the beginning of the year we had a sales order book of £565 million which was lower than the previous year (January 2010: £638 million). At the time we commented that sales rates had been affected by the uncertainty created by the planned austerity measures and the unusually bad weather during November and December.

 

Since then sales rates have improved with the total value of new sales reservations taken in the year to date increasing by c. 12% when compared to the same period last year. Our order book, including legal completions already achieved this year, now stands at a similar level to last year at £1.14 billion.

 

In line with our continuing strategy of margin improvement, these sales will generate further margin growth.

 

Visitor levels to site remain encouraging and cancellation rates continue at a low level of c. 16%. As outlined previously, we anticipate legally completing a similar number of new home sales during 2011 when compared with 2010, but with an increase in volume over the prior year in the second half of 2011. Whilst underlying prices remain stable we expect average selling prices to show improvement due to our strategy of continued mix change with more Charles Church homes being completed and a greater proportion of traditional family housing.

 

We have continued to take action to optimise our debt portfolio given our strong liquidity and significant cash holdings. On 25 March 2011 we prepaid our remaining Senior Loan Notes with a face value of £136.4 million. The finance cost savings that will result from this action will significantly exceed the initial costs.

 

On 1 April 2011 we arranged a new five year £300 million revolving credit facility, which replaces our existing facility which was due to mature on 31 March 2012. The financing received strong support and was substantially over subscribed. Royal Bank of Scotland Group plc, Lloyds Banking Group, Barclays Bank plc and HSBC Bank plc acted as mandated lead arrangers joined by Santander UK Ltd and Yorkshire Bank. Receiving such strong support from our long term relationship banks places us in an excellent position. Together with our continued strong liquidity and balance sheet we remain keen to invest in new development opportunities to deliver the future success of Persimmon.

 

Gearing continues to run at low levels and was c. 6% at the end of March (31 March 2010: 17%) as we run up to the point of our peak working capital requirements.

 

Recent Government initiatives announced in the Budget in respect of planning changes and support for first time buyers are helpful and, whilst an improvement in mortgage supply would improve market conditions, we are operating successfully at the current levels of activity.

 

In the meantime, we continue to secure opportunities to grow our business further whilst maintaining our focus on margin growth.

 

We will give a further update on trading on Tuesday 5 July 2011.

 

 

For further information, please contact:

 

 

 

Edward Orlebar

Charlotte McMullen

Marylène Guernier

 

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Persimmon plc

M:Communications

Tel: +44 (0) 20 7920 2369 (on 21 April 2011)

Tel: +44 (0) 19 0464 2199 (thereafter)

Tel: +44 (0) 20 7920 2369

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSURSNRABASUAR
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.